Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Solid Tumors 1Pancreatic Neoplasms 1Neoplasms 1Gastric Cancer Adenocarcinoma Metastatic 1CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1

Interventions

Oxaliplatin 166Capecitabine 112Fluorouracil 95Docetaxel 85Cisplatin 84S 1 (combination) 83Leucovorin 64Paclitaxel 58Irinotecan 56pembrolizumab 36sintilimab 34Trastuzumab 34apatinib 30Bevacizumab 21Surgical Procedures, Operative 19Radiotherapy 19titanium silicide 17camrelizumab 17Nivolumab 17Ramucirumab 16Drug Therapy 15Hyperthermic Intraperitoneal Chemotherapy 14Folfox protocol 14Epirubicin 14tislelizumab 13Neoadjuvant Therapy 12Cetuximab 12XELOX 10Tegafur 10Carboplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Stomach Neoplasms × zolbetuximab × Clear all
NCT03505320 2026-04-03

ILUSTRO

Astellas Pharma Inc

Phase 2 Active not recruiting
143 enrolled
Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT06468280 2026-01-21

ROSETTE

Shanghai Zhongshan Hospital

Phase 2 Recruiting
84 enrolled
Gastrointestinal

Stomach Neoplasms

NCT06881017 2025-03-18

Establishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular Subtyping

China Medical University, China

Phase 2 Not yet recruiting
140 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡